AIRLINK 155.22 Increased By ▲ 3.10 (2.04%)
BOP 9.58 Increased By ▲ 0.46 (5.04%)
CNERGY 7.10 Increased By ▲ 0.01 (0.14%)
CPHL 84.21 Increased By ▲ 1.92 (2.33%)
FCCL 43.90 Increased By ▲ 1.09 (2.55%)
FFL 14.85 Increased By ▲ 0.64 (4.5%)
FLYNG 30.10 Increased By ▲ 1.51 (5.28%)
HUBC 135.18 Increased By ▲ 3.24 (2.46%)
HUMNL 12.68 Increased By ▲ 0.45 (3.68%)
KEL 4.08 Increased By ▲ 0.08 (2%)
KOSM 5.10 Increased By ▲ 0.19 (3.87%)
MLCF 69.80 Increased By ▲ 2.75 (4.1%)
OGDC 204.00 Increased By ▲ 3.62 (1.81%)
PACE 5.10 Increased By ▲ 0.11 (2.2%)
PAEL 42.59 Increased By ▲ 1.09 (2.63%)
PIAHCLA 16.60 Increased By ▲ 0.38 (2.34%)
PIBTL 8.78 Increased By ▲ 0.36 (4.28%)
POWER 13.45 Increased By ▲ 0.40 (3.07%)
PPL 151.77 Increased By ▲ 3.17 (2.13%)
PRL 28.59 Increased By ▲ 0.88 (3.18%)
PTC 20.72 Increased By ▲ 1.26 (6.47%)
SEARL 84.61 Increased By ▲ 2.64 (3.22%)
SSGC 38.58 Increased By ▲ 1.31 (3.51%)
SYM 14.70 Increased By ▲ 0.32 (2.23%)
TELE 6.95 Increased By ▲ 0.13 (1.91%)
TPLP 8.25 Increased By ▲ 0.11 (1.35%)
TRG 64.07 Increased By ▲ 0.94 (1.49%)
WAVESAPP 8.60 Increased By ▲ 0.56 (6.97%)
WTL 1.28 Increased By ▲ 0.03 (2.4%)
YOUW 3.50 Increased By ▲ 0.15 (4.48%)
AIRLINK 155.22 Increased By ▲ 3.10 (2.04%)
BOP 9.58 Increased By ▲ 0.46 (5.04%)
CNERGY 7.10 Increased By ▲ 0.01 (0.14%)
CPHL 84.21 Increased By ▲ 1.92 (2.33%)
FCCL 43.90 Increased By ▲ 1.09 (2.55%)
FFL 14.85 Increased By ▲ 0.64 (4.5%)
FLYNG 30.10 Increased By ▲ 1.51 (5.28%)
HUBC 135.18 Increased By ▲ 3.24 (2.46%)
HUMNL 12.68 Increased By ▲ 0.45 (3.68%)
KEL 4.08 Increased By ▲ 0.08 (2%)
KOSM 5.10 Increased By ▲ 0.19 (3.87%)
MLCF 69.80 Increased By ▲ 2.75 (4.1%)
OGDC 204.00 Increased By ▲ 3.62 (1.81%)
PACE 5.10 Increased By ▲ 0.11 (2.2%)
PAEL 42.59 Increased By ▲ 1.09 (2.63%)
PIAHCLA 16.60 Increased By ▲ 0.38 (2.34%)
PIBTL 8.78 Increased By ▲ 0.36 (4.28%)
POWER 13.45 Increased By ▲ 0.40 (3.07%)
PPL 151.77 Increased By ▲ 3.17 (2.13%)
PRL 28.59 Increased By ▲ 0.88 (3.18%)
PTC 20.72 Increased By ▲ 1.26 (6.47%)
SEARL 84.61 Increased By ▲ 2.64 (3.22%)
SSGC 38.58 Increased By ▲ 1.31 (3.51%)
SYM 14.70 Increased By ▲ 0.32 (2.23%)
TELE 6.95 Increased By ▲ 0.13 (1.91%)
TPLP 8.25 Increased By ▲ 0.11 (1.35%)
TRG 64.07 Increased By ▲ 0.94 (1.49%)
WAVESAPP 8.60 Increased By ▲ 0.56 (6.97%)
WTL 1.28 Increased By ▲ 0.03 (2.4%)
YOUW 3.50 Increased By ▲ 0.15 (4.48%)
BR100 12,121 Increased By 344.9 (2.93%)
BR30 35,374 Increased By 964 (2.8%)
KSE100 113,955 Increased By 2628 (2.36%)
KSE30 34,878 Increased By 885.3 (2.6%)

Consumer healthcare company Haleon Pakistan Limited on Thursday named Qawi Naseer as the next Chief Executive Officer (CEO) of the company, as the current CEO and Executive Director of the Board Farhan Muhammad Haroon to be transferred to Haleon South Africa as General Manager.

The company announced the development in a notice to the Pakistan Stock Exchange (PSX).

“This is to inform shareholders that after an outstanding career with Haleon Pakistan Limited (the ‘Company’), Mr Farhan Muhammad Haroon, currently the Chief Executive Officer and Executive Director of the Board, Pakistan will be transferred to Haleon South Africa as General Manager, effective 1 June 2025.

“The Board of Directors approved the transfer and thanked Mr Haroon for his dedicated service and leadership, which led to significant business growth. Mr Haroon shall continue to hold the office of Chief Executive Officer and Executive Director of the Board till 31 May 2025,” the notice read.

Interview with Farhan Muhammad Haroon, CEO and General Manager - Haleon Pakistan

It further said the Board of Directors decided to appoint Mr Qawi Naseer, who will join the company April 28, 2025 as Chief Executive Officer (Designate).

He will be appointed CEO and Executive Director of the Board, effective 1 June 2025.

A separate but corresponding announcement would be issued in accordance with PUCARS timings upon the change of Mr Naseer’s designation to CEO and Executive Director to the Board, effective 1 June 2025, the company said.

“Mr Naseer is a dynamic and accomplished business leader with a track record of driving transformative growth and innovation in the consumer goods industry,” the notice read.

Last month, Haleon Pakistan Limited, formerly known as GlaxoSmithKline Consumer Healthcare Pakistan Limited, announced that it had successfully exported Centrum—a well-known multivitamin brand—from its manufacturing facility in Jamshoro to Kenya.

“We are pleased to share that Haleon Pakistan Limited has successfully dispatched the first consignment of Centrum, manufactured at our facility in Jamshoro, to Kenya,” read its notice to the PSX then.

“This important milestone marks the beginning of an exciting journey, further enhancing our export operations in the year 2025. The successful shipment is a testament to our commitment to support the economy of Pakistan, opening new doors to growth opportunities in the international market,” it added.

According to the information available on the company’s website, it has a global presence with commercial operations in more than 150 countries, a network of 86 manufacturing sites in 36 countries and large research and development (R&D) centres in the UK, USA, Spain, Belgium and China.

Comments

200 characters